Parkinson's disease: Evaluation and therapeutic strategy

Research output: Contribution to journalArticle

Abstract

A 'designer drug' that touched off a mysterious epidemic of parkinsonism has provided insights into a basic pathologic process of the disease - destruction of dopaminergic neurons. These insights have also helped correlate clinical approaches with biomedical events, opening the way for development of more effective pharmacologic agents for a still relentlessly progressive disorder.

Original languageEnglish (US)
Pages (from-to)107-138
Number of pages32
JournalHospital Practice
Volume22
Issue number4
StatePublished - 1987
Externally publishedYes

Fingerprint

Designer Drugs
Dopaminergic Neurons
Parkinsonian Disorders
Pathologic Processes
Parkinson Disease
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Parkinson's disease : Evaluation and therapeutic strategy. / Nutt, John.

In: Hospital Practice, Vol. 22, No. 4, 1987, p. 107-138.

Research output: Contribution to journalArticle

@article{dd2875ce066e4a56a517f6a25e997abd,
title = "Parkinson's disease: Evaluation and therapeutic strategy",
abstract = "A 'designer drug' that touched off a mysterious epidemic of parkinsonism has provided insights into a basic pathologic process of the disease - destruction of dopaminergic neurons. These insights have also helped correlate clinical approaches with biomedical events, opening the way for development of more effective pharmacologic agents for a still relentlessly progressive disorder.",
author = "John Nutt",
year = "1987",
language = "English (US)",
volume = "22",
pages = "107--138",
journal = "Hospital practice (1995)",
issn = "2154-8331",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - Parkinson's disease

T2 - Evaluation and therapeutic strategy

AU - Nutt, John

PY - 1987

Y1 - 1987

N2 - A 'designer drug' that touched off a mysterious epidemic of parkinsonism has provided insights into a basic pathologic process of the disease - destruction of dopaminergic neurons. These insights have also helped correlate clinical approaches with biomedical events, opening the way for development of more effective pharmacologic agents for a still relentlessly progressive disorder.

AB - A 'designer drug' that touched off a mysterious epidemic of parkinsonism has provided insights into a basic pathologic process of the disease - destruction of dopaminergic neurons. These insights have also helped correlate clinical approaches with biomedical events, opening the way for development of more effective pharmacologic agents for a still relentlessly progressive disorder.

UR - http://www.scopus.com/inward/record.url?scp=0023217306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023217306&partnerID=8YFLogxK

M3 - Article

C2 - 3104356

AN - SCOPUS:0023217306

VL - 22

SP - 107

EP - 138

JO - Hospital practice (1995)

JF - Hospital practice (1995)

SN - 2154-8331

IS - 4

ER -